BOLD
Boundless Bio, Inc.
Price Chart
Latest Quote
$1.43
+0.03 (+2.14%)
Current Price
| Previous Close | $1.40 |
| Open | $1.41 |
| Day High | $1.43 |
| Day Low | $1.41 |
| Volume | 62,172 |
Stock Information
| Shares Outstanding | 22.46M |
| Total Debt | $48.29M |
| Cash Equivalents | $92.85M |
| Net Income | $-55.99M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $32.12M |
| EPS (TTM) | $-2.49 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-12.89M |
| Income | $-55.99M |
| Book/sh | $3.85 |
| Cash/sh | $4.13 |
| Employees | 28 |
Financial Ratios
| Quick Ratio | 9.69 |
| Current Ratio | 9.87 |
| Debt/Eq | 55.90 |
Returns & Margins
| ROA | -22.83% |
| ROE | -50.22% |
Ownership
| Insider Ownership | 11.35% |
| Institutional Ownership | 49.77% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.12 |
| P/B | 0.37 |
Analyst Data
| Recommendation | none |
| Target Price | $4.00 |
Technical Indicators
| SMA20 | $1.43 |
| SMA50 | $1.46 |
| SMA200 | $1.26 |
| RSI | 46.15 |
| ATR | 0.0491 |
| Shares Float | 16.41M |
| Short Float | 0.05% |
| Short Ratio | 0.05 |
| Volatility | 0.97 |
| Rel Volume | 1.21 |
Performance History
| Week | +2.88% |
| Month | +2.14% |
| Quarter | +24.35% |
| 6 Months | +25.44% |
| YTD | +17.21% |
| Year | +36.19% |
| 10 Years | -89.96% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.43 | 80,200 |
| 2026-06-17 | $1.40 | 65,000 |
| 2026-06-16 | $1.41 | 141,100 |
| 2026-06-15 | $1.40 | 23,000 |
| 2026-06-12 | $1.41 | 9,700 |
| 2026-06-11 | $1.39 | 37,500 |
| 2026-06-10 | $1.38 | 52,600 |
| 2026-06-09 | $1.40 | 116,500 |
| 2026-06-08 | $1.43 | 71,000 |
| 2026-06-05 | $1.42 | 60,200 |
| 2026-06-04 | $1.47 | 72,200 |
| 2026-06-03 | $1.44 | 134,400 |
| 2026-06-02 | $1.43 | 27,600 |
| 2026-06-01 | $1.44 | 71,700 |
| 2026-05-29 | $1.45 | 45,300 |
| 2026-05-28 | $1.46 | 46,700 |
| 2026-05-27 | $1.47 | 81,900 |
| 2026-05-26 | $1.47 | 79,300 |
| 2026-05-22 | $1.44 | 72,800 |
| 2026-05-21 | $1.45 | 39,600 |
| 2026-05-20 | $1.42 | 100,200 |
| 2026-05-19 | $1.40 | 50,100 |
About Boundless Bio, Inc.
Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as well as patients with triple-negative breast cancer luminal androgen receptor subtype. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
đ° Latest News
Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's Why
Zacks âĸ 2026-02-13T17:00:04Z
We're Keeping An Eye On Boundless Bio's (NASDAQ:BOLD) Cash Burn Rate
Simply Wall St. âĸ 2026-01-31T14:19:19Z
Here's Why We're Watching Boundless Bio's (NASDAQ:BOLD) Cash Burn Situation
Simply Wall St. âĸ 2025-08-24T13:43:39Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $63,552,000 | $73,267,000 | $54,796,000 | $46,469,000 |
| Other Income Expense | $-2,000 | $12,000 | $80,000 | $-100,000 |
| Other Non Operating Income Expenses | $-2,000 | $12,000 | $80,000 | $-100,000 |
| Net Non Operating Interest Income Expense | $5,357,000 | $7,892,000 | $5,282,000 | $668,000 |
| Operating Expense | $63,552,000 | $73,267,000 | $54,796,000 | $46,469,000 |
| General And Administrative Expense | $18,707,000 | $18,000,000 | $12,159,000 | $9,310,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-58,197,000 | $-65,363,000 | $-49,434,000 | $-45,901,000 |
| Net Interest Income | $5,357,000 | $7,892,000 | $5,282,000 | $668,000 |
| Interest Income | $5,357,000 | $7,892,000 | $5,282,000 | $668,000 |
| Normalized Income | $-58,197,000 | $-65,363,000 | $-49,434,000 | $-45,901,000 |
| Net Income From Continuing And Discontinued Operation | $-58,197,000 | $-65,363,000 | $-49,434,000 | $-45,901,000 |
| Total Operating Income As Reported | $-63,552,000 | $-73,267,000 | $-54,796,000 | $-46,469,000 |
| Net Income Common Stockholders | $-58,197,000 | $-65,363,000 | $-49,434,000 | $-45,901,000 |
| Net Income | $-58,197,000 | $-65,363,000 | $-49,434,000 | $-45,901,000 |
| Net Income Including Noncontrolling Interests | $-58,197,000 | $-65,363,000 | $-49,434,000 | $-45,901,000 |
| Net Income Continuous Operations | $-58,197,000 | $-65,363,000 | $-49,434,000 | $-45,901,000 |
| Pretax Income | $-58,197,000 | $-65,363,000 | $-49,434,000 | $-45,901,000 |
| Interest Income Non Operating | $5,357,000 | $7,892,000 | $5,282,000 | $668,000 |
| Operating Income | $-63,552,000 | $-73,267,000 | $-54,796,000 | $-46,469,000 |
| Per Share | ||||
| Diluted EPS | $-2.60 | $-3.85 | $-2.22 | $-3.28 |
| Basic EPS | $-2.60 | $-3.85 | $-2.22 | $-3.28 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-62,301,000 | $-72,181,000 | $-53,839,000 | $-45,527,000 |
| Reconciled Depreciation | $1,251,000 | $1,086,000 | $957,000 | $942,000 |
| EBITDA (Bullshit earnings) | $-62,301,000 | $-72,181,000 | $-53,839,000 | $-45,527,000 |
| EBIT | $-63,552,000 | $-73,267,000 | $-54,796,000 | $-46,469,000 |
| Diluted Average Shares | $22,360,000 | $16,984,000 | $22,239,333 | $13,990,000 |
| Basic Average Shares | $22,360,000 | $16,984,000 | $22,239,333 | $13,990,000 |
| Diluted NI Availto Com Stockholders | $-58,197,000 | $-65,363,000 | $-49,434,000 | $-45,901,000 |
| Research And Development | $44,845,000 | $55,267,000 | $42,637,000 | $37,159,000 |
| Selling General And Administration | $18,707,000 | $18,000,000 | $12,159,000 | $9,310,000 |
| Other Gand A | $18,707,000 | $18,000,000 | $12,159,000 | $9,310,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $98,654,000 | $150,642,000 | $-127,082,000 | $-81,696,000 |
| Total Assets | $157,059,000 | $206,409,000 | $129,894,000 | $76,829,000 |
| Total Non Current Assets | $47,448,000 | $52,019,000 | $5,690,000 | $8,792,000 |
| Other Non Current Assets | $573,000 | $659,000 | $1,115,000 | $1,066,000 |
| Current Assets | $109,611,000 | $154,390,000 | $124,204,000 | $68,037,000 |
| Other Current Assets | $2,030,000 | $2,276,000 | $3,452,000 | $1,320,000 |
| Cash Cash Equivalents And Short Term Investments | $107,581,000 | $152,114,000 | $120,752,000 | $66,717,000 |
| Cash And Cash Equivalents | $17,868,000 | $26,587,000 | $23,706,000 | $10,951,000 |
| Debt | ||||
| Total Debt | $49,035,000 | $47,632,000 | $2,195,000 | $5,183,000 |
| Long Term Debt And Capital Lease Obligation | $45,868,000 | $47,632,000 | $0 | $2,845,000 |
| Current Debt And Capital Lease Obligation | $3,167,000 | - | $2,195,000 | $2,338,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $58,405,000 | $55,767,000 | $256,976,000 | $158,525,000 |
| Total Non Current Liabilities Net Minority Interest | $45,868,000 | $47,632,000 | $247,617,000 | $150,797,000 |
| Current Liabilities | $12,537,000 | $8,135,000 | $9,359,000 | $7,728,000 |
| Payables And Accrued Expenses | $6,727,000 | $5,354,000 | $4,266,000 | $2,838,000 |
| Payables | $1,491,000 | $1,274,000 | $2,222,000 | $1,402,000 |
| Accounts Payable | $1,491,000 | $1,274,000 | $2,222,000 | $1,402,000 |
| Other Non Current Liabilities | - | - | - | $6,000 |
| Other Current Liabilities | - | - | - | $93,000 |
| Equity | ||||
| Common Stock Equity | $98,654,000 | $150,642,000 | $-127,082,000 | $-81,696,000 |
| Total Equity Gross Minority Interest | $98,654,000 | $150,642,000 | $-127,082,000 | $-81,696,000 |
| Stockholders Equity | $98,654,000 | $150,642,000 | $-127,082,000 | $-81,696,000 |
| Gains Losses Not Affecting Retained Earnings | $64,000 | $121,000 | $40,000 | $-398,000 |
| Other Equity Adjustments | $64,000 | $121,000 | $40,000 | $-398,000 |
| Retained Earnings | $-259,669,000 | $-201,472,000 | $-136,109,000 | $-86,675,000 |
| Preferred Securities Outside Stock Equity | - | $0 | $247,617,000 | $147,946,000 |
| Other | ||||
| Ordinary Shares Number | $22,407,000 | $22,300,043 | $22,239,333 | $22,239,333 |
| Share Issued | $22,407,000 | $22,300,043 | $22,239,333 | $22,239,333 |
| Tangible Book Value | $98,654,000 | $150,642,000 | $-127,082,000 | $-81,696,000 |
| Invested Capital | $98,654,000 | $150,642,000 | $-127,082,000 | $-81,696,000 |
| Working Capital | $97,074,000 | $146,255,000 | $114,845,000 | $60,309,000 |
| Capital Lease Obligations | $49,035,000 | $47,632,000 | $2,195,000 | $5,183,000 |
| Total Capitalization | $98,654,000 | $150,642,000 | $-127,082,000 | $-81,696,000 |
| Additional Paid In Capital | $358,257,000 | $351,991,000 | $8,987,000 | $5,377,000 |
| Capital Stock | $2,000 | $2,000 | $0 | $0 |
| Common Stock | $2,000 | $2,000 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | - |
| Long Term Capital Lease Obligation | $45,868,000 | $47,632,000 | $0 | $2,845,000 |
| Current Capital Lease Obligation | $3,167,000 | $0 | $2,195,000 | $2,338,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,643,000 | $2,781,000 | $2,898,000 | $2,459,000 |
| Current Accrued Expenses | $5,236,000 | $4,080,000 | $2,044,000 | $1,436,000 |
| Net PPE | $46,875,000 | $51,360,000 | $4,575,000 | $7,726,000 |
| Accumulated Depreciation | $-4,960,000 | $-3,709,000 | $-2,727,000 | $-1,811,000 |
| Gross PPE | $51,835,000 | $55,069,000 | $7,302,000 | $9,537,000 |
| Leases | $1,054,000 | $981,000 | $46,000 | $46,000 |
| Other Properties | $48,032,000 | $51,377,000 | $6,266,000 | $8,665,000 |
| Machinery Furniture Equipment | $2,749,000 | $2,711,000 | $990,000 | $826,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $89,713,000 | $125,527,000 | $97,046,000 | $55,766,000 |
| Investments And Advances | - | - | - | $0 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-47,207,000 | $-63,377,000 | $-47,488,000 | $-40,662,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-46,661,000 | $-60,841,000 | $-46,855,000 | $-39,596,000 |
| Cash Flow From Continuing Operating Activities | $-46,661,000 | $-60,841,000 | $-46,855,000 | $-39,596,000 |
| Investing Activities | ||||
| Capital Expenditure | $-546,000 | $-2,536,000 | $-633,000 | $-1,066,000 |
| Investing Cash Flow | $37,801,000 | $-26,101,000 | $-38,260,000 | $16,132,000 |
| Cash Flow From Continuing Investing Activities | $37,801,000 | $-26,101,000 | $-38,260,000 | $16,132,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $93,000,000 | $99,671,000 | $0 |
| Financing Cash Flow | $141,000 | $89,823,000 | $97,897,000 | $126,000 |
| Cash Flow From Continuing Financing Activities | $141,000 | $89,823,000 | $97,897,000 | $126,000 |
| Net Common Stock Issuance | $0 | $93,000,000 | $0 | - |
| Common Stock Issuance | $0 | $93,000,000 | $0 | - |
| Net Other Financing Charges | - | $-3,349,000 | $-1,956,000 | - |
| Net Preferred Stock Issuance | - | $0 | $99,671,000 | $0 |
| Preferred Stock Issuance | - | $0 | $99,671,000 | $0 |
| Other | ||||
| End Cash Position | $18,428,000 | $27,147,000 | $24,266,000 | $11,484,000 |
| Beginning Cash Position | $27,147,000 | $24,266,000 | $11,484,000 | $34,822,000 |
| Changes In Cash | $-8,719,000 | $2,881,000 | $12,782,000 | $-23,338,000 |
| Proceeds From Stock Option Exercised | $141,000 | $172,000 | $182,000 | $126,000 |
| Net Investment Purchase And Sale | $38,347,000 | $-23,565,000 | $-37,627,000 | $17,198,000 |
| Sale Of Investment | $213,244,000 | $184,900,000 | $122,496,000 | $59,796,000 |
| Purchase Of Investment | $-174,897,000 | $-208,465,000 | $-160,123,000 | $-42,598,000 |
| Net PPE Purchase And Sale | $-546,000 | $-2,536,000 | $-633,000 | $-1,066,000 |
| Purchase Of PPE | $-546,000 | $-2,536,000 | $-633,000 | $-1,066,000 |
| Change In Working Capital | $3,462,000 | $-1,678,000 | $-799,000 | $866,000 |
| Change In Other Current Liabilities | $1,496,000 | $-2,151,000 | $-2,547,000 | $-1,262,000 |
| Change In Payables And Accrued Expense | $1,634,000 | $775,000 | $1,663,000 | $1,911,000 |
| Change In Prepaid Assets | $332,000 | $-302,000 | $85,000 | $217,000 |
| Other Non Cash Items | $3,288,000 | $2,653,000 | $2,385,000 | $1,704,000 |
| Stock Based Compensation | $6,125,000 | $7,516,000 | $3,336,000 | $2,290,000 |
| Amortization Of Securities | $-2,590,000 | $-5,055,000 | $-3,300,000 | $503,000 |
| Depreciation Amortization Depletion | $1,251,000 | $1,086,000 | $957,000 | $942,000 |
| Depreciation And Amortization | $1,251,000 | $1,086,000 | $957,000 | $942,000 |
| Net Income From Continuing Operations | $-58,197,000 | $-65,363,000 | $-49,434,000 | $-45,901,000 |
| Depreciation | - | - | $957,000 | $942,000 |
Fetched: 2026-06-18